Skip to main content

Research Repository

Advanced Search

HYBRID CORONARY REVASCULARIZATION VERSUS CORONARY ARTERY BYPASS GRAFT IN PATIENTS WITH MULTIVESSEL CORONARY ARTERY DISEASE A META-ANALYSIS

Zghouzi, Mohamed; Ullah, Waqas; Sandhyavenu, Hariogopal; Pacha, Homam Moussa; Al-Khadra, Yasser; Ahmad, Bachar; Sattar, Yasar; Suleiman, Abdul-Rahman; Garcia, Santiago; Bagur, Rodrigo; Ali, Omar; Gardi, Delair; Hakim, Zaher; Mohamed, Mohamed; Rashid, Muhammad; Mamas, Mamas; Alraies, M. Chadi

Authors

Mohamed Zghouzi

Waqas Ullah

Hariogopal Sandhyavenu

Homam Moussa Pacha

Yasser Al-Khadra

Bachar Ahmad

Yasar Sattar

Abdul-Rahman Suleiman

Santiago Garcia

Rodrigo Bagur

Omar Ali

Delair Gardi

Zaher Hakim

Mohamed Mohamed

M. Chadi Alraies



Abstract

Background
Hybrid coronary artery revascularization (HCR) refers to complete or near complete revascularization using the combination of single vessel CABG and PCI of other significant coronary lesions. The short-term outcomes of HCR compared to CABG alone is unknown.

Methods
Online databases were queried with various combinations of keywords to identify relevant articles. Major adverse cardiovascular events (MACE) and its components were compared using a random effect model to calculate unadjusted odds ratios (OR).

Results
A total of 36 studies comprising 213,053 patients (HCR 4,276, CABG 208,777) were included. The odds of MACE (OR 1.22; 95% CI 0.86-1.74; P=0.27), repeat MI (OR 1.02; 95% CI 0.66-1.60; P=0.91), cerebrovascular events (OR 0.82; 95% CI 0.55-1.24; P=0.35), all cause mortality (OR 1.13; 95% CI 0.72-1.79; P=0.59), AKI (OR 1.09; 95% CI 0.55-2.19; P=0.8), hemodialysis (OR 0.49; 95% CI 0.14-1.66; P=0.25), postoperative Afib (OR 0.76; 95% CI 0.53-1.09; P=0.13), complete revascularization (OR 0.97; 95% CI 0.62-1.52; P=0.9), and TVR (OR 2.68; 95% CI 0.47-15.25; P=0.27) were not different between the two groups. Although the odds of blood transfusion requirement was significantly lower in the HCR group (OR 0.37; 95% CI 0.31-0.44; P<0.001), the need for repeat operation due to bleeding was similar between the two groups (OR 1.03; 95% CI 0.75-1.42; P=0.84).

Conclusion
Clinical outcomes of HCR and CABG were comparable for patients with MCAD, with no difference in mortality or major adverse events.

Citation

Zghouzi, M., Ullah, W., Sandhyavenu, H., Pacha, H. M., Al-Khadra, Y., Ahmad, B., Sattar, Y., Suleiman, A.-R., Garcia, S., Bagur, R., Ali, O., Gardi, D., Hakim, Z., Mohamed, M., Rashid, M., Mamas, M., & Alraies, M. C. (2021). HYBRID CORONARY REVASCULARIZATION VERSUS CORONARY ARTERY BYPASS GRAFT IN PATIENTS WITH MULTIVESSEL CORONARY ARTERY DISEASE A META-ANALYSIS. Journal of the American College of Cardiology, 77(18), 1042. https://doi.org/10.1016/s0735-1097%2821%2902401-3

Journal Article Type Article
Acceptance Date May 3, 2021
Online Publication Date May 3, 2021
Publication Date 2021-05
Deposit Date Jun 23, 2023
Journal Journal of the American College of Cardiology
Print ISSN 0735-1097
Electronic ISSN 1558-3597
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 77
Issue 18
Pages 1042
DOI https://doi.org/10.1016/s0735-1097%2821%2902401-3
Keywords Cardiology and Cardiovascular Medicine
Public URL https://keele-repository.worktribe.com/output/503542